Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Lung Carcinoma Metastatic in the Brain × Ferrosoferric Oxide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Brain Neoplasms 3 Urinary Bladder Neoplasms 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Prostatic Neoplasms 1 Osteosarcoma 1 Osteonecrosis 1 Osteomyelitis 1 Lung Carcinoma Metastatic in the Brain 1 Kidney Neoplasms 1 Glioblastoma 1 Cranial Nerve Diseases 1 Chondrosarcoma 1 Central Nervous System Neoplasms 1 Bone Neoplasms 1

Interventions

pembrolizumab 1 Magnetic Resonance Spectroscopy 1 Ferrosoferric Oxide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03325166 2022-08-10

Pembrolizumab and Magnetic Resonance Imaging With Ferumoxytol in Treating Patients With Non-small Cell Lung Cancer and Brain Metastases

OHSU Knight Cancer Institute

Phase 2 Terminated

2 enrolled 8 charts

Lung Carcinoma Metastatic in the Brain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡